Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment on the Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section. A Retrospective, Monocenter, Observational Study in Daily Practice

NCT05807633 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.

NCT NCT05807633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05807633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment on the Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section. A Retrospective, Monocenter, Observational Study in Daily Practice
Lead sponsor
Aesculap AG
Phase
Observational
Overall status
Completed
Start date
June 15, 2022
Completion date
October 1, 2023
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section complications, cesarean section; infection